======= DPH6 =======
== Gene Information ==
* **Official Symbol**: DPH6
* **Official Name**: diphthamine biosynthesis 6
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=89978|89978]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q7L8W6|Q7L8W6]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=DPH6&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20DPH6|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/618391|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: Amidase that catalyzes the last step of diphthamide biosynthesis using ammonium and ATP. Diphthamide biosynthesis consists in the conversion of an L-histidine residue in the translation elongation factor (EEF2) to diphthamide (By similarity). {ECO:0000250, ECO:0000269|PubMed:23169644}.
|ATP bind 4|
|diphthine-ammonia ligase activity|
|peptidyl-diphthamide biosynthetic process from peptidyl-histidine|
|peptidyl-diphthamide metabolic process|
|regulation of cytoplasmic translational elongation|
|peptidyl-histidine modification|
|regulation of translational elongation|
|regulation of cytoplasmic translation|
|regulation of translation|
|regulation of cellular amide metabolic process|
|posttranscriptional regulation of gene expression|
|nucleolus|
|peptidyl-amino acid modification|
|ATP binding|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp215|Colchicine 0.009μM R05 exp215]]|-2.18|
|[[:results:exp113|1-Methyl-nicotinamide-chloride 1000μM R03 exp113]]|-1.89|
|[[:results:exp245|UM0011500 5μM R05 exp245]]|-1.79|
|[[:results:exp499|LY2090314 0.003μM R08 exp499]]|-1.73|
|[[:results:exp502|Milciclib 2μM R08 exp502]]|1.74|
|[[:results:exp275|Citral 75μM R06 exp275]]|1.75|
|[[:results:exp505|ML-792 0.2μM R08 exp505]]|1.82|
|[[:results:exp183|IU1-C 25μM R04 exp183]]|1.93|
|[[:results:exp513|ONC212 0.15μM R08 exp513]]|1.95|
|[[:results:exp497|Lead acetate 2000μM R08 exp497]]|1.96|
|[[:results:exp525|Sulforaphane 9μM R08 exp525]]|2.04|
|[[:results:exp94|Nocodazole 0.1μM R03 exp94]]|2.13|
|[[:results:exp440|Aphidicolin 0.4μM R08 exp440]]|2.24|
|[[:results:exp290|LLY-283 2.6μM R06 exp290]]|2.36|
|[[:results:exp488|Hippuristanol 0.12μM R08 exp488]]|2.38|
|[[:results:exp363|GSK-J4 1-1.25μM to day4 R07 exp363]]|2.41|
|[[:results:exp147|Resveratrol 16μM R03 exp147]]|2.45|
|[[:results:exp526|Sulforaphane 9μM R08 exp526 no dilution day6]]|2.56|
|[[:results:exp489|Hippuristanol 0.12μM R08 exp489 no dilution day6]]|2.59|
|[[:results:exp274|Citral 50μM R06 exp274]]|2.67|
|[[:results:exp116|AICAR 240μM R03 exp116]]|2.76|
|[[:results:exp134|MS023 2μM R03 exp134]]|2.92|
|[[:results:exp135|MS023 7μM R03 exp135]]|3.02|
|[[:results:exp6|Bortezomib 0.005μM R00 exp6]]|3.4|
|[[:results:exp468|CB-5083 0.4μM R08 exp468]]|3.64|
^Gene^Correlation^
|[[:human genes:d:dph5|DPH5]]|0.694|
|[[:human genes:d:dph1|DPH1]]|0.602|
|[[:human genes:d:dnajc24|DNAJC24]]|0.572|
|[[:human genes:d:dph2|DPH2]]|0.546|
|[[:human genes:z:zzz3|ZZZ3]]|0.466|
|[[:human genes:m:mapkap1|MAPKAP1]]|0.465|
|[[:human genes:s:sbds|SBDS]]|0.455|
|[[:human genes:u:urm1|URM1]]|0.437|
|[[:human genes:t:tpt1|TPT1]]|0.428|
Global Fraction of Cell Lines Where Essential: 30/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|2/28|
|bone|1/26|
|breast|2/33|
|central nervous system|1/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|1/21|
|liver|1/20|
|lung|2/75|
|lymphocyte|1/16|
|ovary|2/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|1/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|2/22|
|urinary tract|1/29|
|uterus|1/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 7575
* **Expression level (log2 read counts)**: 4.25
{{:chemogenomics:nalm6 dist.png?nolink |}}